Solventum CEO Bryan Hanson's $40 million pay package makes him one of the highest-paid CEOs in medtech for 2024.
Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.
CEO Bryan Hanson told investors last week that the restructuring plan would save Solventum $120 million annually.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback